Service & Software
Global White Biotech Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 568895
- Pages: 126
- Figures: 124
- Views: 2
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global White Biotech market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Biosynth
Dupont
DSM NV
BASF
Evonik Industries AG
Lonza Group Ltd
Laurus Bio
Novozymes
Cargill Incorporated
Archer Daniels Midland Company
Segment by Type
Biofuels
Biomaterials
Biochemicals
Industrial Enzymes
Others
Segment by Application
Bioenergy
Pharmaceuticals
Food & Beverages
Feed
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the White Biotech study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global White Biotech market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Biosynth
Dupont
DSM NV
BASF
Evonik Industries AG
Lonza Group Ltd
Laurus Bio
Novozymes
Cargill Incorporated
Archer Daniels Midland Company
Segment by Type
Biofuels
Biomaterials
Biochemicals
Industrial Enzymes
Others
Segment by Application
Bioenergy
Pharmaceuticals
Food & Beverages
Feed
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the White Biotech study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to White Biotech: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global White Biotech Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biofuels
1.2.3 Biomaterials
1.2.4 Biochemicals
1.2.5 Industrial Enzymes
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global White Biotech Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bioenergy
1.3.3 Pharmaceuticals
1.3.4 Food & Beverages
1.3.5 Feed
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global White Biotech Revenue Estimates and Forecasts 2020-2031
2.2 Global White Biotech Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global White Biotech Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global White Biotech Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biofuels Market Size by Players
3.3.2 Biomaterials Market Size by Players
3.3.3 Biochemicals Market Size by Players
3.3.4 Industrial Enzymes Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global White Biotech Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global White Biotech Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global White Biotech Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America White Biotech Market Size by Type (2020-2031)
6.4 North America White Biotech Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America White Biotech Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe White Biotech Market Size by Type (2020-2031)
7.4 Europe White Biotech Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe White Biotech Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific White Biotech Market Size by Type (2020-2031)
8.4 Asia-Pacific White Biotech Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific White Biotech Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America White Biotech Market Size by Type (2020-2031)
9.4 Central and South America White Biotech Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America White Biotech Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa White Biotech Market Size by Type (2020-2031)
10.4 Middle East and Africa White Biotech Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa White Biotech Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Biosynth
11.1.1 Biosynth Corporation Information
11.1.2 Biosynth Business Overview
11.1.3 Biosynth White Biotech Product Features and Attributes
11.1.4 Biosynth White Biotech Revenue and Gross Margin (2020-2025)
11.1.5 Biosynth White Biotech Revenue by Product in 2024
11.1.6 Biosynth White Biotech Revenue by Application in 2024
11.1.7 Biosynth White Biotech Revenue by Geographic Area in 2024
11.1.8 Biosynth White Biotech SWOT Analysis
11.1.9 Biosynth Recent Developments
11.2 Dupont
11.2.1 Dupont Corporation Information
11.2.2 Dupont Business Overview
11.2.3 Dupont White Biotech Product Features and Attributes
11.2.4 Dupont White Biotech Revenue and Gross Margin (2020-2025)
11.2.5 Dupont White Biotech Revenue by Product in 2024
11.2.6 Dupont White Biotech Revenue by Application in 2024
11.2.7 Dupont White Biotech Revenue by Geographic Area in 2024
11.2.8 Dupont White Biotech SWOT Analysis
11.2.9 Dupont Recent Developments
11.3 DSM NV
11.3.1 DSM NV Corporation Information
11.3.2 DSM NV Business Overview
11.3.3 DSM NV White Biotech Product Features and Attributes
11.3.4 DSM NV White Biotech Revenue and Gross Margin (2020-2025)
11.3.5 DSM NV White Biotech Revenue by Product in 2024
11.3.6 DSM NV White Biotech Revenue by Application in 2024
11.3.7 DSM NV White Biotech Revenue by Geographic Area in 2024
11.3.8 DSM NV White Biotech SWOT Analysis
11.3.9 DSM NV Recent Developments
11.4 BASF
11.4.1 BASF Corporation Information
11.4.2 BASF Business Overview
11.4.3 BASF White Biotech Product Features and Attributes
11.4.4 BASF White Biotech Revenue and Gross Margin (2020-2025)
11.4.5 BASF White Biotech Revenue by Product in 2024
11.4.6 BASF White Biotech Revenue by Application in 2024
11.4.7 BASF White Biotech Revenue by Geographic Area in 2024
11.4.8 BASF White Biotech SWOT Analysis
11.4.9 BASF Recent Developments
11.5 Evonik Industries AG
11.5.1 Evonik Industries AG Corporation Information
11.5.2 Evonik Industries AG Business Overview
11.5.3 Evonik Industries AG White Biotech Product Features and Attributes
11.5.4 Evonik Industries AG White Biotech Revenue and Gross Margin (2020-2025)
11.5.5 Evonik Industries AG White Biotech Revenue by Product in 2024
11.5.6 Evonik Industries AG White Biotech Revenue by Application in 2024
11.5.7 Evonik Industries AG White Biotech Revenue by Geographic Area in 2024
11.5.8 Evonik Industries AG White Biotech SWOT Analysis
11.5.9 Evonik Industries AG Recent Developments
11.6 Lonza Group Ltd
11.6.1 Lonza Group Ltd Corporation Information
11.6.2 Lonza Group Ltd Business Overview
11.6.3 Lonza Group Ltd White Biotech Product Features and Attributes
11.6.4 Lonza Group Ltd White Biotech Revenue and Gross Margin (2020-2025)
11.6.5 Lonza Group Ltd Recent Developments
11.7 Laurus Bio
11.7.1 Laurus Bio Corporation Information
11.7.2 Laurus Bio Business Overview
11.7.3 Laurus Bio White Biotech Product Features and Attributes
11.7.4 Laurus Bio White Biotech Revenue and Gross Margin (2020-2025)
11.7.5 Laurus Bio Recent Developments
11.8 Novozymes
11.8.1 Novozymes Corporation Information
11.8.2 Novozymes Business Overview
11.8.3 Novozymes White Biotech Product Features and Attributes
11.8.4 Novozymes White Biotech Revenue and Gross Margin (2020-2025)
11.8.5 Novozymes Recent Developments
11.9 Cargill Incorporated
11.9.1 Cargill Incorporated Corporation Information
11.9.2 Cargill Incorporated Business Overview
11.9.3 Cargill Incorporated White Biotech Product Features and Attributes
11.9.4 Cargill Incorporated White Biotech Revenue and Gross Margin (2020-2025)
11.9.5 Cargill Incorporated Recent Developments
11.10 Archer Daniels Midland Company
11.10.1 Archer Daniels Midland Company Corporation Information
11.10.2 Archer Daniels Midland Company Business Overview
11.10.3 Archer Daniels Midland Company White Biotech Product Features and Attributes
11.10.4 Archer Daniels Midland Company White Biotech Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 White BiotechIndustry Chain Analysis
12.1 White Biotech Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 White Biotech Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global White Biotech Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to White Biotech: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global White Biotech Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biofuels
1.2.3 Biomaterials
1.2.4 Biochemicals
1.2.5 Industrial Enzymes
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global White Biotech Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bioenergy
1.3.3 Pharmaceuticals
1.3.4 Food & Beverages
1.3.5 Feed
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global White Biotech Revenue Estimates and Forecasts 2020-2031
2.2 Global White Biotech Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global White Biotech Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global White Biotech Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biofuels Market Size by Players
3.3.2 Biomaterials Market Size by Players
3.3.3 Biochemicals Market Size by Players
3.3.4 Industrial Enzymes Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global White Biotech Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global White Biotech Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global White Biotech Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America White Biotech Market Size by Type (2020-2031)
6.4 North America White Biotech Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America White Biotech Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe White Biotech Market Size by Type (2020-2031)
7.4 Europe White Biotech Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe White Biotech Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific White Biotech Market Size by Type (2020-2031)
8.4 Asia-Pacific White Biotech Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific White Biotech Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America White Biotech Market Size by Type (2020-2031)
9.4 Central and South America White Biotech Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America White Biotech Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa White Biotech Market Size by Type (2020-2031)
10.4 Middle East and Africa White Biotech Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa White Biotech Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Biosynth
11.1.1 Biosynth Corporation Information
11.1.2 Biosynth Business Overview
11.1.3 Biosynth White Biotech Product Features and Attributes
11.1.4 Biosynth White Biotech Revenue and Gross Margin (2020-2025)
11.1.5 Biosynth White Biotech Revenue by Product in 2024
11.1.6 Biosynth White Biotech Revenue by Application in 2024
11.1.7 Biosynth White Biotech Revenue by Geographic Area in 2024
11.1.8 Biosynth White Biotech SWOT Analysis
11.1.9 Biosynth Recent Developments
11.2 Dupont
11.2.1 Dupont Corporation Information
11.2.2 Dupont Business Overview
11.2.3 Dupont White Biotech Product Features and Attributes
11.2.4 Dupont White Biotech Revenue and Gross Margin (2020-2025)
11.2.5 Dupont White Biotech Revenue by Product in 2024
11.2.6 Dupont White Biotech Revenue by Application in 2024
11.2.7 Dupont White Biotech Revenue by Geographic Area in 2024
11.2.8 Dupont White Biotech SWOT Analysis
11.2.9 Dupont Recent Developments
11.3 DSM NV
11.3.1 DSM NV Corporation Information
11.3.2 DSM NV Business Overview
11.3.3 DSM NV White Biotech Product Features and Attributes
11.3.4 DSM NV White Biotech Revenue and Gross Margin (2020-2025)
11.3.5 DSM NV White Biotech Revenue by Product in 2024
11.3.6 DSM NV White Biotech Revenue by Application in 2024
11.3.7 DSM NV White Biotech Revenue by Geographic Area in 2024
11.3.8 DSM NV White Biotech SWOT Analysis
11.3.9 DSM NV Recent Developments
11.4 BASF
11.4.1 BASF Corporation Information
11.4.2 BASF Business Overview
11.4.3 BASF White Biotech Product Features and Attributes
11.4.4 BASF White Biotech Revenue and Gross Margin (2020-2025)
11.4.5 BASF White Biotech Revenue by Product in 2024
11.4.6 BASF White Biotech Revenue by Application in 2024
11.4.7 BASF White Biotech Revenue by Geographic Area in 2024
11.4.8 BASF White Biotech SWOT Analysis
11.4.9 BASF Recent Developments
11.5 Evonik Industries AG
11.5.1 Evonik Industries AG Corporation Information
11.5.2 Evonik Industries AG Business Overview
11.5.3 Evonik Industries AG White Biotech Product Features and Attributes
11.5.4 Evonik Industries AG White Biotech Revenue and Gross Margin (2020-2025)
11.5.5 Evonik Industries AG White Biotech Revenue by Product in 2024
11.5.6 Evonik Industries AG White Biotech Revenue by Application in 2024
11.5.7 Evonik Industries AG White Biotech Revenue by Geographic Area in 2024
11.5.8 Evonik Industries AG White Biotech SWOT Analysis
11.5.9 Evonik Industries AG Recent Developments
11.6 Lonza Group Ltd
11.6.1 Lonza Group Ltd Corporation Information
11.6.2 Lonza Group Ltd Business Overview
11.6.3 Lonza Group Ltd White Biotech Product Features and Attributes
11.6.4 Lonza Group Ltd White Biotech Revenue and Gross Margin (2020-2025)
11.6.5 Lonza Group Ltd Recent Developments
11.7 Laurus Bio
11.7.1 Laurus Bio Corporation Information
11.7.2 Laurus Bio Business Overview
11.7.3 Laurus Bio White Biotech Product Features and Attributes
11.7.4 Laurus Bio White Biotech Revenue and Gross Margin (2020-2025)
11.7.5 Laurus Bio Recent Developments
11.8 Novozymes
11.8.1 Novozymes Corporation Information
11.8.2 Novozymes Business Overview
11.8.3 Novozymes White Biotech Product Features and Attributes
11.8.4 Novozymes White Biotech Revenue and Gross Margin (2020-2025)
11.8.5 Novozymes Recent Developments
11.9 Cargill Incorporated
11.9.1 Cargill Incorporated Corporation Information
11.9.2 Cargill Incorporated Business Overview
11.9.3 Cargill Incorporated White Biotech Product Features and Attributes
11.9.4 Cargill Incorporated White Biotech Revenue and Gross Margin (2020-2025)
11.9.5 Cargill Incorporated Recent Developments
11.10 Archer Daniels Midland Company
11.10.1 Archer Daniels Midland Company Corporation Information
11.10.2 Archer Daniels Midland Company Business Overview
11.10.3 Archer Daniels Midland Company White Biotech Product Features and Attributes
11.10.4 Archer Daniels Midland Company White Biotech Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 White BiotechIndustry Chain Analysis
12.1 White Biotech Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 White Biotech Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global White Biotech Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global White Biotech Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global White Biotech Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global White Biotech Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global White Biotech Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global White Biotech Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global White Biotech Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global White Biotech Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global White Biotech by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in White Biotech as of 2024)
Table 11. Global White Biotech Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global White Biotech Companies Headquarters
Table 13. Global White Biotech Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global White Biotech Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global White Biotech Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global White Biotech Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global White Biotech Revenue by Application (2026-2031) & (US$ Million)
Table 21. White Biotech High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America White Biotech Growth Accelerators and Market Barriers
Table 25. North America White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe White Biotech Growth Accelerators and Market Barriers
Table 27. Europe White Biotech Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific White Biotech Growth Accelerators and Market Barriers
Table 29. Asia-Pacific White Biotech Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America White Biotech Investment Opportunities and Key Challenges
Table 31. Central and South America White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa White Biotech Investment Opportunities and Key Challenges
Table 33. Middle East and Africa White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Biosynth Corporation Information
Table 35. Biosynth Description and Major Businesses
Table 36. Biosynth Product Features and Attributes
Table 37. Biosynth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Biosynth Revenue Proportion by Product in 2024
Table 39. Biosynth Revenue Proportion by Application in 2024
Table 40. Biosynth Revenue Proportion by Geographic Area in 2024
Table 41. Biosynth White Biotech SWOT Analysis
Table 42. Biosynth Recent Developments
Table 43. Dupont Corporation Information
Table 44. Dupont Description and Major Businesses
Table 45. Dupont Product Features and Attributes
Table 46. Dupont Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Dupont Revenue Proportion by Product in 2024
Table 48. Dupont Revenue Proportion by Application in 2024
Table 49. Dupont Revenue Proportion by Geographic Area in 2024
Table 50. Dupont White Biotech SWOT Analysis
Table 51. Dupont Recent Developments
Table 52. DSM NV Corporation Information
Table 53. DSM NV Description and Major Businesses
Table 54. DSM NV Product Features and Attributes
Table 55. DSM NV Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. DSM NV Revenue Proportion by Product in 2024
Table 57. DSM NV Revenue Proportion by Application in 2024
Table 58. DSM NV Revenue Proportion by Geographic Area in 2024
Table 59. DSM NV White Biotech SWOT Analysis
Table 60. DSM NV Recent Developments
Table 61. BASF Corporation Information
Table 62. BASF Description and Major Businesses
Table 63. BASF Product Features and Attributes
Table 64. BASF Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BASF Revenue Proportion by Product in 2024
Table 66. BASF Revenue Proportion by Application in 2024
Table 67. BASF Revenue Proportion by Geographic Area in 2024
Table 68. BASF White Biotech SWOT Analysis
Table 69. BASF Recent Developments
Table 70. Evonik Industries AG Corporation Information
Table 71. Evonik Industries AG Description and Major Businesses
Table 72. Evonik Industries AG Product Features and Attributes
Table 73. Evonik Industries AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Evonik Industries AG Revenue Proportion by Product in 2024
Table 75. Evonik Industries AG Revenue Proportion by Application in 2024
Table 76. Evonik Industries AG Revenue Proportion by Geographic Area in 2024
Table 77. Evonik Industries AG White Biotech SWOT Analysis
Table 78. Evonik Industries AG Recent Developments
Table 79. Lonza Group Ltd Corporation Information
Table 80. Lonza Group Ltd Description and Major Businesses
Table 81. Lonza Group Ltd Product Features and Attributes
Table 82. Lonza Group Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Lonza Group Ltd Recent Developments
Table 84. Laurus Bio Corporation Information
Table 85. Laurus Bio Description and Major Businesses
Table 86. Laurus Bio Product Features and Attributes
Table 87. Laurus Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Laurus Bio Recent Developments
Table 89. Novozymes Corporation Information
Table 90. Novozymes Description and Major Businesses
Table 91. Novozymes Product Features and Attributes
Table 92. Novozymes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novozymes Recent Developments
Table 94. Cargill Incorporated Corporation Information
Table 95. Cargill Incorporated Description and Major Businesses
Table 96. Cargill Incorporated Product Features and Attributes
Table 97. Cargill Incorporated Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Cargill Incorporated Recent Developments
Table 99. Archer Daniels Midland Company Corporation Information
Table 100. Archer Daniels Midland Company Description and Major Businesses
Table 101. Archer Daniels Midland Company Product Features and Attributes
Table 102. Archer Daniels Midland Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Archer Daniels Midland Company Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. White Biotech Product Picture
Figure 2. Global White Biotech Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biofuels Product Picture
Figure 4. Biomaterials Product Picture
Figure 5. Biochemicals Product Picture
Figure 6. Industrial Enzymes Product Picture
Figure 7. Others Product Picture
Figure 8. Global White Biotech Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Bioenergy
Figure 10. Pharmaceuticals
Figure 11. Food & Beverages
Figure 12. Feed
Figure 13. Others
Figure 14. White Biotech Report Years Considered
Figure 15. Global White Biotech Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global White Biotech Revenue (2020-2031) & (US$ Million)
Figure 17. Global White Biotech Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global White Biotech Revenue Market Share by Region (2020-2031)
Figure 19. Global White Biotech Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Biofuels Revenue Market Share by Player in 2024
Figure 22. Biomaterials Revenue Market Share by Player in 2024
Figure 23. Biochemicals Revenue Market Share by Player in 2024
Figure 24. Industrial Enzymes Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global White Biotech Revenue Market Share by Type (2020-2031)
Figure 27. Global White Biotech Revenue Market Share by Application (2020-2031)
Figure 28. North America White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 30. North America White Biotech Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 32. US White Biotech Revenue (2020-2031) & (US$ Million)
Figure 33. Canada White Biotech Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico White Biotech Revenue (2020-2031) & (US$ Million)
Figure 35. Europe White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 37. Europe White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany White Biotech Revenue (2020-2031) & (US$ Million)
Figure 40. France White Biotech Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. White Biotech Revenue (2020-2031) & (US$ Million)
Figure 42. Italy White Biotech Revenue (2020-2031) & (US$ Million)
Figure 43. Russia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players White Biotech Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 49. Japan White Biotech Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea White Biotech Revenue (2020-2031) & (US$ Million)
Figure 51. Australia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 52. India White Biotech Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam White Biotech Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines White Biotech Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore White Biotech Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 60. Central and South America White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil White Biotech Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina White Biotech Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 66. South America White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries White Biotech Revenue (2020-2025) & (US$ Million)
Figure 69. Israel White Biotech Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt White Biotech Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa White Biotech Revenue (2020-2025) & (US$ Million)
Figure 72. White Biotech Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Table 1. Global White Biotech Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global White Biotech Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global White Biotech Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global White Biotech Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global White Biotech Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global White Biotech Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global White Biotech Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global White Biotech by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in White Biotech as of 2024)
Table 11. Global White Biotech Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global White Biotech Companies Headquarters
Table 13. Global White Biotech Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global White Biotech Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global White Biotech Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global White Biotech Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global White Biotech Revenue by Application (2026-2031) & (US$ Million)
Table 21. White Biotech High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America White Biotech Growth Accelerators and Market Barriers
Table 25. North America White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe White Biotech Growth Accelerators and Market Barriers
Table 27. Europe White Biotech Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific White Biotech Growth Accelerators and Market Barriers
Table 29. Asia-Pacific White Biotech Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America White Biotech Investment Opportunities and Key Challenges
Table 31. Central and South America White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa White Biotech Investment Opportunities and Key Challenges
Table 33. Middle East and Africa White Biotech Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Biosynth Corporation Information
Table 35. Biosynth Description and Major Businesses
Table 36. Biosynth Product Features and Attributes
Table 37. Biosynth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Biosynth Revenue Proportion by Product in 2024
Table 39. Biosynth Revenue Proportion by Application in 2024
Table 40. Biosynth Revenue Proportion by Geographic Area in 2024
Table 41. Biosynth White Biotech SWOT Analysis
Table 42. Biosynth Recent Developments
Table 43. Dupont Corporation Information
Table 44. Dupont Description and Major Businesses
Table 45. Dupont Product Features and Attributes
Table 46. Dupont Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Dupont Revenue Proportion by Product in 2024
Table 48. Dupont Revenue Proportion by Application in 2024
Table 49. Dupont Revenue Proportion by Geographic Area in 2024
Table 50. Dupont White Biotech SWOT Analysis
Table 51. Dupont Recent Developments
Table 52. DSM NV Corporation Information
Table 53. DSM NV Description and Major Businesses
Table 54. DSM NV Product Features and Attributes
Table 55. DSM NV Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. DSM NV Revenue Proportion by Product in 2024
Table 57. DSM NV Revenue Proportion by Application in 2024
Table 58. DSM NV Revenue Proportion by Geographic Area in 2024
Table 59. DSM NV White Biotech SWOT Analysis
Table 60. DSM NV Recent Developments
Table 61. BASF Corporation Information
Table 62. BASF Description and Major Businesses
Table 63. BASF Product Features and Attributes
Table 64. BASF Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BASF Revenue Proportion by Product in 2024
Table 66. BASF Revenue Proportion by Application in 2024
Table 67. BASF Revenue Proportion by Geographic Area in 2024
Table 68. BASF White Biotech SWOT Analysis
Table 69. BASF Recent Developments
Table 70. Evonik Industries AG Corporation Information
Table 71. Evonik Industries AG Description and Major Businesses
Table 72. Evonik Industries AG Product Features and Attributes
Table 73. Evonik Industries AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Evonik Industries AG Revenue Proportion by Product in 2024
Table 75. Evonik Industries AG Revenue Proportion by Application in 2024
Table 76. Evonik Industries AG Revenue Proportion by Geographic Area in 2024
Table 77. Evonik Industries AG White Biotech SWOT Analysis
Table 78. Evonik Industries AG Recent Developments
Table 79. Lonza Group Ltd Corporation Information
Table 80. Lonza Group Ltd Description and Major Businesses
Table 81. Lonza Group Ltd Product Features and Attributes
Table 82. Lonza Group Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Lonza Group Ltd Recent Developments
Table 84. Laurus Bio Corporation Information
Table 85. Laurus Bio Description and Major Businesses
Table 86. Laurus Bio Product Features and Attributes
Table 87. Laurus Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Laurus Bio Recent Developments
Table 89. Novozymes Corporation Information
Table 90. Novozymes Description and Major Businesses
Table 91. Novozymes Product Features and Attributes
Table 92. Novozymes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novozymes Recent Developments
Table 94. Cargill Incorporated Corporation Information
Table 95. Cargill Incorporated Description and Major Businesses
Table 96. Cargill Incorporated Product Features and Attributes
Table 97. Cargill Incorporated Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Cargill Incorporated Recent Developments
Table 99. Archer Daniels Midland Company Corporation Information
Table 100. Archer Daniels Midland Company Description and Major Businesses
Table 101. Archer Daniels Midland Company Product Features and Attributes
Table 102. Archer Daniels Midland Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Archer Daniels Midland Company Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. White Biotech Product Picture
Figure 2. Global White Biotech Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biofuels Product Picture
Figure 4. Biomaterials Product Picture
Figure 5. Biochemicals Product Picture
Figure 6. Industrial Enzymes Product Picture
Figure 7. Others Product Picture
Figure 8. Global White Biotech Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Bioenergy
Figure 10. Pharmaceuticals
Figure 11. Food & Beverages
Figure 12. Feed
Figure 13. Others
Figure 14. White Biotech Report Years Considered
Figure 15. Global White Biotech Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global White Biotech Revenue (2020-2031) & (US$ Million)
Figure 17. Global White Biotech Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global White Biotech Revenue Market Share by Region (2020-2031)
Figure 19. Global White Biotech Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Biofuels Revenue Market Share by Player in 2024
Figure 22. Biomaterials Revenue Market Share by Player in 2024
Figure 23. Biochemicals Revenue Market Share by Player in 2024
Figure 24. Industrial Enzymes Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global White Biotech Revenue Market Share by Type (2020-2031)
Figure 27. Global White Biotech Revenue Market Share by Application (2020-2031)
Figure 28. North America White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 30. North America White Biotech Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 32. US White Biotech Revenue (2020-2031) & (US$ Million)
Figure 33. Canada White Biotech Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico White Biotech Revenue (2020-2031) & (US$ Million)
Figure 35. Europe White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 37. Europe White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany White Biotech Revenue (2020-2031) & (US$ Million)
Figure 40. France White Biotech Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. White Biotech Revenue (2020-2031) & (US$ Million)
Figure 42. Italy White Biotech Revenue (2020-2031) & (US$ Million)
Figure 43. Russia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players White Biotech Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 49. Japan White Biotech Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea White Biotech Revenue (2020-2031) & (US$ Million)
Figure 51. Australia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 52. India White Biotech Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam White Biotech Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia White Biotech Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines White Biotech Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore White Biotech Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 60. Central and South America White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil White Biotech Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina White Biotech Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa White Biotech Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players White Biotech Revenue (US$ Million) in 2024
Figure 66. South America White Biotech Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa White Biotech Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries White Biotech Revenue (2020-2025) & (US$ Million)
Figure 69. Israel White Biotech Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt White Biotech Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa White Biotech Revenue (2020-2025) & (US$ Million)
Figure 72. White Biotech Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232